Watson Biotech: Response to the review inquiry letter on the application of Yunnan Watson Biotechnology Co., Ltd. to issue convertible corporate bonds to an unspecified target

SZSI · Jun 29, 2023 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.